Emami Group's arm companies, M Bhattacharyya and King & Co., have forged a strategic technical collaboration with Hevert, one of the top ten manufacturers of homoeopathic medicines in the world based at Nussbaum, Germany. M Bhattacharyya and King & Co are based in Kolkata and belonging to well diversified Emami Group engaged in different sectors like FMCG, paper, edible oil, etc.
Under this strategic partnership, three agreements have been signed for distribution & marketing, GMP consultancy and licence for manufacturing select Hevert formulations in India. The process of manufacturing will start from the month of April 2015. The objective of this collaboration is to make world class German homoeopathic remedies available in India by importing, marketing & manufacturing them in India by M Bhattacharyya & Co. Pvt. Ltd. and King & Co. (Homoeo Chemist) Pvt. Ltd.
Riding on the rising consumer shift for side-effect free medicine, the Rs.1,500 crore homoeopathy pharma segment has been growing at a fast clip of 25 per cent annually. With this joint venture, Emami Group has upped its ante to aggressively enter the premium homoeopathy medicine segment in India—initially by importing and marketing the Hevert medicines from Germany followed by manufacturing the formulations in India.
The formal announcement to this joint venture was made at a press conference organized in Kolkata today. It was attended by Mathias Hevert, managing director, Hevert, Juergen Kuhlmann, sales director international & export, Hevert, Dr Ralf Weirich, head marketing/sales/export, Hevert, Rainer Schmiedchen, consul general, German Consulate, Kolkata, Krishna Mardi, Jt Secretary, Dept of Health & Family Welfare, GoWB, R S Goenka, founder & Jt chairman, Emami Group of Companies and R K Jatia, director, King & Co.
As a part of the said venture, presently, M Bhattacharyya has emerged as the sole importer and distributor for six homoeopathic products from Hevert stable in India. These products are namely Hevert Cold & Flu Relief, Hevert Cough Relief, Hevert Stress Relief, Hevert Vertigo Relief, Hevert Pain Relief and Hevert Allergy Relief. The products will be available in 400 homoeopathy medicine retail outlets across diverse distribution channels. There are plans to import and market two other medicines at a later date, namely, Hevert Sinus Relief and Hevert Stomach Relief.
Hailing this strategic relationship, R S Agarwal, Founder & joint chairman, Emami Group of Companies said that, “Homoeopathy is a vast area of knowledge and it is necessary to keep ourselves updated with significant international developments in this area of treatment. As a homoeopathic brand, M Bhattacharyya has been enjoying people’s trust for over 120 years. However, to stay relevant with the passing time, it is necessary to keep pace with advanced developments happening globally. We were always open for strategic technical collaboration with international homoeopathic firms and I am confident that our partnership with Hevert is going to benefit the consumers in India immensely.”
R S Goenka, founder & joint chairman, Emami Group of Companies added that, “German homoeopathic medicines are highly accepted and trusted by consumers across the world. Therefore, this Indo-German association in the field of homoeopathic and natural medicines will go a long way in changing the course of homoeopathic treatment in India. Together we share a common philosophy of making people healthy and beautiful and pledge to take good health to every household in India”.
R K Jatia, director King & Co said, “I take pride in announcing that the year 2014-15 shall be a landmark year in Indian homoeopathic industry wherein we shall import world class products for Indian market. Our existing facility at Madhyamgram has been specially upgraded to comply with the EU GMP norms which will enable us to manufacture select Hevert products in India”
Mathias Hevert, managing director of Hevert-Arzneimittel GmbH & Co.KG said that, “We are really happy and proud to offer our proven homoeopathic products to Indian people with the help of our partner M Bhattacharyya & Co. Private Limited. Our main stay is quality. Our products are of very high standards with minimum side effects and are naturally effective. A large number of our formulas were created in collaboration with students of the famous Pastor Emanuel Felke, one of the pioneers of naturopathy and the co-founder of complex homoeopathy. With continuous improvements, these medicines have already proven their efficacy to millions of patients worldwide with very low rate of side effects.”
Emami Group of Companies enjoy a strong presence in other areas of healthcare through its various Group Companies. While, Emami Limited, the flagship Company of the Group, manufactures ayurvedic OTC, generic and ethical drugs under the Zandu portfolio, Emami Frank Ross is a landmark brand in the field of retail pharmacy in the country. AMRI Hospitals, also owned by Emami Group, is one of the largest chain of hospitals in the private sector in Eastern India, while, M Bhattacharyya and King & Co., both Emami Group companies, are trusted names in homoeopathic and natural medicines for more than a century.
M Bhattacharyya & Co. Pvt. Limited was acquired by Emami Group on April 1, 2007. M Bhattacharyya & Co. Pvt. Limited offers homoeopathy products like mother tinctures, dilutions, biochemic remedies, biochemic combinations, and trituration; and offers special formulations, including cardiolif for heart, diabetol for diabetes, alfalfa tonic with ginseng for general health, Liverquin syrup for liver, and coughkure syrup for cough, and babycare products.
Source:Pharmabiz
Under this strategic partnership, three agreements have been signed for distribution & marketing, GMP consultancy and licence for manufacturing select Hevert formulations in India. The process of manufacturing will start from the month of April 2015. The objective of this collaboration is to make world class German homoeopathic remedies available in India by importing, marketing & manufacturing them in India by M Bhattacharyya & Co. Pvt. Ltd. and King & Co. (Homoeo Chemist) Pvt. Ltd.
Riding on the rising consumer shift for side-effect free medicine, the Rs.1,500 crore homoeopathy pharma segment has been growing at a fast clip of 25 per cent annually. With this joint venture, Emami Group has upped its ante to aggressively enter the premium homoeopathy medicine segment in India—initially by importing and marketing the Hevert medicines from Germany followed by manufacturing the formulations in India.
The formal announcement to this joint venture was made at a press conference organized in Kolkata today. It was attended by Mathias Hevert, managing director, Hevert, Juergen Kuhlmann, sales director international & export, Hevert, Dr Ralf Weirich, head marketing/sales/export, Hevert, Rainer Schmiedchen, consul general, German Consulate, Kolkata, Krishna Mardi, Jt Secretary, Dept of Health & Family Welfare, GoWB, R S Goenka, founder & Jt chairman, Emami Group of Companies and R K Jatia, director, King & Co.
As a part of the said venture, presently, M Bhattacharyya has emerged as the sole importer and distributor for six homoeopathic products from Hevert stable in India. These products are namely Hevert Cold & Flu Relief, Hevert Cough Relief, Hevert Stress Relief, Hevert Vertigo Relief, Hevert Pain Relief and Hevert Allergy Relief. The products will be available in 400 homoeopathy medicine retail outlets across diverse distribution channels. There are plans to import and market two other medicines at a later date, namely, Hevert Sinus Relief and Hevert Stomach Relief.
Hailing this strategic relationship, R S Agarwal, Founder & joint chairman, Emami Group of Companies said that, “Homoeopathy is a vast area of knowledge and it is necessary to keep ourselves updated with significant international developments in this area of treatment. As a homoeopathic brand, M Bhattacharyya has been enjoying people’s trust for over 120 years. However, to stay relevant with the passing time, it is necessary to keep pace with advanced developments happening globally. We were always open for strategic technical collaboration with international homoeopathic firms and I am confident that our partnership with Hevert is going to benefit the consumers in India immensely.”
R S Goenka, founder & joint chairman, Emami Group of Companies added that, “German homoeopathic medicines are highly accepted and trusted by consumers across the world. Therefore, this Indo-German association in the field of homoeopathic and natural medicines will go a long way in changing the course of homoeopathic treatment in India. Together we share a common philosophy of making people healthy and beautiful and pledge to take good health to every household in India”.
R K Jatia, director King & Co said, “I take pride in announcing that the year 2014-15 shall be a landmark year in Indian homoeopathic industry wherein we shall import world class products for Indian market. Our existing facility at Madhyamgram has been specially upgraded to comply with the EU GMP norms which will enable us to manufacture select Hevert products in India”
Mathias Hevert, managing director of Hevert-Arzneimittel GmbH & Co.KG said that, “We are really happy and proud to offer our proven homoeopathic products to Indian people with the help of our partner M Bhattacharyya & Co. Private Limited. Our main stay is quality. Our products are of very high standards with minimum side effects and are naturally effective. A large number of our formulas were created in collaboration with students of the famous Pastor Emanuel Felke, one of the pioneers of naturopathy and the co-founder of complex homoeopathy. With continuous improvements, these medicines have already proven their efficacy to millions of patients worldwide with very low rate of side effects.”
Emami Group of Companies enjoy a strong presence in other areas of healthcare through its various Group Companies. While, Emami Limited, the flagship Company of the Group, manufactures ayurvedic OTC, generic and ethical drugs under the Zandu portfolio, Emami Frank Ross is a landmark brand in the field of retail pharmacy in the country. AMRI Hospitals, also owned by Emami Group, is one of the largest chain of hospitals in the private sector in Eastern India, while, M Bhattacharyya and King & Co., both Emami Group companies, are trusted names in homoeopathic and natural medicines for more than a century.
M Bhattacharyya & Co. Pvt. Limited was acquired by Emami Group on April 1, 2007. M Bhattacharyya & Co. Pvt. Limited offers homoeopathy products like mother tinctures, dilutions, biochemic remedies, biochemic combinations, and trituration; and offers special formulations, including cardiolif for heart, diabetol for diabetes, alfalfa tonic with ginseng for general health, Liverquin syrup for liver, and coughkure syrup for cough, and babycare products.
Source:Pharmabiz
No comments:
Post a Comment